Back to Search
Start Over
Overall survival in first-line HR+/HER2- advanced breast cancer in the era of CDK4/6 inhibitors.
- Source :
-
Annals of Oncology . Aug2024, Vol. 35 Issue 8, p689-691. 3p. - Publication Year :
- 2024
- Subjects :
- *METASTATIC breast cancer
*CYCLIN-dependent kinase inhibitors
*OVERALL survival
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Issue :
- 8
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 178597502
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.06.013